Parametric Portfolio Associates’s Guardant Health GH Stock Holding History

Parametric Portfolio Associates’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$4.66M	Sell	70,394 -192	-0.3%	-$13.1K	﹤0.01%	1899
2021 Q4	$7.06M	Sell	70,586 -531	-0.7%	-$54.9K	﹤0.01%	1630
2021 Q3	$8.89M	Sell	71,117 -10,036	-12%	-$1.19M	0.01%	1447
2021 Q2	$10.1M	Sell	81,153 -34,902	-30%	-$4.69M	0.01%	1385
2021 Q1	$17.7M	Buy	116,055 +7,993	+7%	+$1.21M	0.01%	1236
2020 Q4	$13.9M	Sell	108,062 -7,856	-7%	-$904K	0.01%	1314
2020 Q3	$13M	Sell	115,918 -4,652	-4%	-$426K	0.01%	1203
2020 Q2	$9.78M	Buy	120,570 +44,838	+59%	+$3.61M	0.01%	1394
2020 Q1	$5.27M	Sell	75,732 -2,528	-3%	-$194K	﹤0.01%	1691
2019 Q4	$6.12M	Buy	78,260 +63,626	+435%	+$4.59M	﹤0.01%	1897
2019 Q3	$934K	Sell	14,634 -6,296	-30%	-$555K	﹤0.01%	3061
2019 Q2	$1.81M	Buy	20,930 +4,886	+30%	+$373K	﹤0.01%	2735
2019 Q1	$1.23M	Sell	16,044 -7,835	-33%	-$434K	﹤0.01%	2921
2018 Q4	$898K	Buy	+23,879	New	+$880K	﹤0.01%	3045

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Parametric Portfolio Associates's GH Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Guardant Health (GH) stake by 0.27% in Q1 2022, selling an estimated $13.1K and leaving 70,394 shares worth $4.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1899.

Parametric Portfolio Associates first reported a position in GH in Q4 2018 and has held it in 14 quarters since. The position peaked at $17.7M in Q1 2021. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

Parametric Portfolio Associates held 70,394 shares of Guardant Health worth $4.66M as of Q1 2022.
Parametric Portfolio Associates sold 192 Guardant Health shares in Q1 2022, an estimated $13.1K.
Guardant Health made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1899 holding.
Parametric Portfolio Associates first reported a position in Guardant Health in Q4 2018 and has held it in 14 quarters since.
Parametric Portfolio Associates's Guardant Health position peaked at $17.7M in Q1 2021.
356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.